Zhou Zhou
Manager
Beijing
Education
M.S., epidemiology, Harvard T.H. Chan School of Public Health; B.S., biological sciences, Peking University
Summary of Experience
Ms. Zhou’s expertise is in health economics and outcomes research (HEOR) consulting. She uses statistical and econometric models to support health care decision making across a range of disease areas, including oncology, hematology, rheumatology, and psychiatry. Ms. Zhou has extensive experience conducting studies of comparative effectiveness and cost effectiveness, budget impact analyses, treatment patterns, and burden-of-illness issues. Her work has involved a variety of data types, including administrative claims, clinical trials, patient records, physician surveys, and medical literature. She has presented her research at international conferences and published it in peer-reviewed journals.
Selected Publishing
-
Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer
Journal of Medical Economics. 2019 Feb;22(2):140-150
2019Signorovitch J, Zhou Z, Ryan J, Anhorn R, Chawla A
-
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
Advances in Therapy, 2019
2019Zhou Z, Fan Y, Thomason D, Tang W, Liu X, Zhou ZY, Macaulay D, Fischer A
-
Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States
The Journal of Rheumatology, 2019
2019Zhou Z, Fan Y, Tang W, Liu X, Thomason D, Zhou ZY, Macaulay D, Fischer A
-
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
Blood Advances, 2019
2019Ailawadhi S, Parikh K, Abouzaid S, Zhou Z, Tang W, Clancy Z, Cheung C, Zhou ZY, Xie J
-
Treatment patterns among adults with ADHD receiving long-acting therapy
American Journal of Managed Care. Jul 2018;24(8 Spec No.):SP329-SP337
2018 -
Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States
Current Medical Research and Opinion. Apr 2018;34(4):585-592
2018 -
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study
JCO Precision Oncology, November 2, 2018
2018Chawla A; Janku F; Wheler J; Miller V; Ryan J; Anhorn, R; Zhou Z; Signorovitch J
-
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer: A Network Meta-analysis
Clinical Therapeutics. Apr 2018;40(4):628-639 e623
2018Ayyagari R, Tang D, Patterson-Lomba O, Zhou Z, Xie J, Chandiwana D, Dalal AA, Niravath PA
-
Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States
Journal of Attention Disorders, July 1, 2018
2018 -
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis
Diabetes Therapy. Mar 29 2018.
2018 -
Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2- Advanced Breast Cancer.
Advances in Therapy. Dec 2017;34(12):2566-2584
2017Zhou Z, Tang DH, Xie J, Ayyagari R, Wu E, Niravath PA
-
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
Diabetes Therapy. Jun 2017;8(3):555-571
2017Zhou Z, Chaudhari P, Yang H, Fang AP, Zhao J, Law EH, Wu EQ, Jiang R, Seifeldin R
-
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey
Clinical Therapeutics, 2016 02; 5(2): 209-220
2016Lin PL, Hao Y, Xie J, Li N, Zhong Y, Zhou Z, Signorovitch JE, Wu EQ.
-
Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective
Current Medical Research and Opinion, Opin 2016 03; 32(3): 405-416. e-pub ahead of print 2015/11/14
2016Nazareth T, Li N, Marynchenko M, Zhou Z, Chopra P, Signorovitch J, Wu E, Ahmed S, Marvel J, Sasane R
-
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation
Aliment Pharmacol Ther. 2014 Jul;40(1):83-92
2014Guerin A, Mody R, Fok B, Lasch KL, Zhou Z, Wu EQ, Zhou W, Talley NJ